BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1889934)

  • 1. Failure to induce ovulation with clomiphene citrate and bromocriptine in luteal deficient women athletes.
    De Crée C; Lewin R; Ostyn M
    Int J Sports Med; 1991 Jun; 12(3):269-75. PubMed ID: 1889934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
    Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
    Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocryptine therapy in luteal insufficiency.
    Godó G; Sas M; Falkay G
    Acta Med Acad Sci Hung; 1980; 37(3):283-8. PubMed ID: 7192924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normoprolactinemic anovulation nonresponsive to clomiphene citrate: ovulation induction with bromocriptine.
    Porcile A; Gallardo E; Venegas E
    Fertil Steril; 1990 Jan; 53(1):50-5. PubMed ID: 2295347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteal phase dysfunction.
    Dizerega GS; Ross GT
    Clin Obstet Gynaecol; 1981 Dec; 8(3):733-51. PubMed ID: 6797773
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of the effect of combination treatment with clomiphene and bromocriptine in patients with normoprolactinemic anovulation.
    Yasui T; Irahara M; Shisukawa K; Azuma K; Aono T
    J Endocrinol Invest; 1990; 13(7):549-54. PubMed ID: 2121818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ovulation with clomiphene citrate followed by LH-RH in women.
    Maia H; Barbosa IC; Maia H; Hirsch C; Tironi E; Coutinho EM
    Int J Gynaecol Obstet; 1983 Feb; 21(1):1-6. PubMed ID: 6133787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of ovulation induction.
    Wu CH
    Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for thyroid hormone in the induction of ovulation and corpus luteum function.
    Maruo T; Katayama K; Barnea ER; Mochizuki M
    Horm Res; 1992; 37 Suppl 1():12-8. PubMed ID: 1427622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extended regimen of clomiphene citrate in women unresponsive to standard therapy.
    Lobo RA; Granger LR; Davajan V; Mishell DR
    Fertil Steril; 1982 Jun; 37(6):762-6. PubMed ID: 6211374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with bromocriptine and clomiphene citrate for patients with normoprolactinemic amenorrhea.
    Kubota T; Kamada S; Aso T
    Int J Fertil; 1992; 37(5):277-82. PubMed ID: 1358838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.
    Polson DW; Mason HD; Franks S
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic sonography to help determine the appropriate therapy for luteal phase defects.
    Check JH; Goldberg BB; Kurtz A; Adelson HG; Rankin A
    Int J Fertil; 1984; 29(3):156-8. PubMed ID: 6152253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resumption of pituitary and ovarian activity post-partum: endocrine and ultrasonic observations in bromocriptine-treated women.
    Haartsen JE; Heineman MJ; Elings M; Evers JL; Lancranjan I
    Hum Reprod; 1992 Jul; 7(6):746-50. PubMed ID: 1500468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.